Effect of Phenazopyridine on Prolapse Surgery Voiding Trials

Completed · Phase 3

Conditions studied: Urinary Retention Postoperative

In brief

To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.

Key facts

Study ID

NCT03065075

Run by

University of Massachusetts, Worcester

People needed

152

Starts

2017-02-01

Expected to finish

2019-02-28

Last updated by the study team

2019-04-16

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women undergoing overnight admission after prolapse surgery

You may not qualify if…

• Unable to provide consent
• Under 18 years of age
• Pregnant women
• Prisoners
• Using intermittent self-catheterization preoperatively
• Neurological disease or spinal cord injury resulting in voiding dysfunction
• Undergoing spinal or epidural anesthesia for the procedure
• Allergy to phenazopyridine
• Renal insufficiency
• Liver disease
• Intra-operative bladder injury necessitating use of prolonged indwelling Foley catheter

Where it is running

• University of Massachusetts — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.